LifeVantage (NASDAQ:LFVN) Shares Cross Above Two Hundred Day Moving Average - Here's What Happened

LifeVantage Co. (NASDAQ:LFVN - Get Free Report)'s share price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $7.57 and traded as high as $11.99. LifeVantage shares last traded at $11.40, with a volume of 58,662 shares traded.

LifeVantage Trading Down 0.1 %

The company has a market cap of $144.79 million, a price-to-earnings ratio of 40.71 and a beta of 0.84. The company's 50 day moving average price is $9.27 and its 200 day moving average price is $7.58.

LifeVantage (NASDAQ:LFVN - Get Free Report) last issued its earnings results on Wednesday, August 28th. The company reported $0.14 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.21 by ($0.07). LifeVantage had a return on equity of 27.85% and a net margin of 1.47%. The business had revenue of $48.93 million for the quarter.

LifeVantage Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 17th. Stockholders of record on Monday, September 9th were paid a dividend of $0.04 per share. The ex-dividend date of this dividend was Monday, September 9th. This represents a $0.16 dividend on an annualized basis and a dividend yield of 1.40%. LifeVantage's dividend payout ratio (DPR) is presently 57.14%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Renaissance Technologies LLC grew its holdings in LifeVantage by 2.1% in the second quarter. Renaissance Technologies LLC now owns 855,118 shares of the company's stock valued at $5,490,000 after purchasing an additional 17,300 shares during the last quarter. Hantz Financial Services Inc. acquired a new stake in LifeVantage in the 2nd quarter valued at about $91,000. Vanguard Group Inc. increased its holdings in LifeVantage by 2.8% during the 1st quarter. Vanguard Group Inc. now owns 475,021 shares of the company's stock valued at $2,874,000 after acquiring an additional 12,809 shares in the last quarter. Hillsdale Investment Management Inc. acquired a new position in LifeVantage during the first quarter worth about $76,000. Finally, Acadian Asset Management LLC lifted its holdings in shares of LifeVantage by 2.8% in the first quarter. Acadian Asset Management LLC now owns 228,088 shares of the company's stock valued at $1,378,000 after purchasing an additional 6,121 shares in the last quarter. 35.32% of the stock is currently owned by institutional investors and hedge funds.

About LifeVantage

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.